AN INTERNATIONAL study led by Monash University has discovered the molecular mechanism by which the potentially deadly superbug 'Golden Staph' evades antibiotic treatment, providing the first important clues on how to counter superbug antibiotic resistance.
Monash researchers working with Israel and Singapore colleagues have identified the first clues on how to 'retool' antibiotics to counter bacteria, with the findings published in the journal mBio.
"The bacteria mutates or evolves to change the shape of the molecule to which the antibiotic would bind so the drug can no longer fit there," BDI lead researcher Dr Matt Belousoff said.
Researchers are now using this information to investigate other drug-resistant bacteria.
Visit mbio.asm.org for the paper.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 May 17
